Capricor Therapeutics, Inc. (CAPR)
After hours:
| Previous close | 5.42 |
| Open | 5.42 |
| Bid | 5.29 x 200 |
| Ask | 5.33 x 100 |
| Day's range | 5.24 - 5.47 |
| 52-week range | 2.68 - 8.22 |
| Volume | |
| Avg. volume | 329,234 |
| Market cap | 170.116M |
| Beta (5Y monthly) | 4.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.83 |
| Earnings date | 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.00 |
GlobeNewswireCapricor Therapeutics to Present Exosome Platform Updates at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
-Preclinical findings show exosome-based therapeutic approach for the treatment of arginase-1 deficiency (ARG1-D)- -Presentation to be featured in an oral session being held on May 9, 2024- SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that an abstract featuring new preclinical data highlighting the therapeutic potential of
- GlobeNewswire
Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at various upcoming scientific and medical conferences. Event:American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting (Baltimore, MD)Date:May 7–11, 2024Format:Oral Presentation/Abstract: Exosome-mediated intracellular delivery
- GlobeNewswire
Capricor Therapeutics to Present First Quarter 2024 Financial Results and Recent Corporate Update on May 13
Company to Host Conference Call, May 13, 2024 at 4:30 p.m. ETSAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the first quarter ended March 31, 2024, after the market close on Monday, May 13, 2024. Management will then host a webcast and conference call at 4:30 p.m. ET on May 13. Title:Capricor Therapeuti
